Linden Thomas Advisory Services’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Linden Thomas Advisory Services’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.06M	Sell	54,401 -402	-0.7%	-$29.6K	0.32%	77
2026 Q2	$3.5M	Sell	54,803 -66,974	-55%	-$3.47M	0.28%	90
2026 Q1	$5.86M	Buy	121,777 +7,315	+6%	+$324K	0.57%	22
2025 Q4	$4.72M	Sell	114,462 -1,578	-1%	-$63.3K	0.48%	48
2025 Q3	$4.51M	Sell	116,040 -75	-0.1%	-$2.44K	0.46%	51
2025 Q2	$3.21M	Sell	116,115 -1,166	-1%	-$29.7K	0.35%	74
2025 Q1	$2.6M	Sell	117,281 -323	-0.3%	-$6.65K	0.34%	80
2024 Q4	$2.33M	Sell	117,604 -106	-0.1%	-$2.42K	0.29%	99
2024 Q3	$2.94M	Sell	117,710 -592	-0.5%	-$14.4K	0.4%	55
2024 Q2	$2.21M	Buy	118,302 +1,921	+2%	+$36K	0.34%	72
2024 Q1	$2.3M	Buy	116,381 +1,831	+2%	+$35.8K	0.37%	61
2023 Q4	$2.01M	Sell	114,550 -1,341	-1%	-$22K	0.38%	66
2023 Q3	$2.01M	Buy	115,891 +57,942	+100%	+$976K	0.45%	45
2023 Q2	$816K	Buy	+57,949	New	+$776K	0.18%	230

Other funds holding KNSA

Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

Sigma Planning Corp Ann Arbor, Michigan $3.88B AUM 23.38% 1-Year Est. Return

Fonville Wealth Management Richmond, Virginia $663M AUM 11.84% 1-Year Est. Return

Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Linden Thomas Advisory Services's KNSA Position: Q3 2026 in Review

Linden Thomas Advisory Services reduced its Kiniksa Pharmaceuticals (KNSA) stake by 0.73% in Q3 2026, selling an estimated $29.6K and leaving 54,401 shares worth $4.06M. The position accounts for 0.32% of the portfolio, ranked #77.

Linden Thomas Advisory Services first reported a position in KNSA in Q2 2023 and has held it in 14 quarters since. The position peaked at $5.86M in Q1 2026. 58 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

Linden Thomas Advisory Services held 54,401 shares of Kiniksa Pharmaceuticals worth $4.06M as of Q3 2026.
Linden Thomas Advisory Services sold 402 Kiniksa Pharmaceuticals shares in Q3 2026, an estimated $29.6K.
Kiniksa Pharmaceuticals made up 0.32% of Linden Thomas Advisory Services's portfolio in Q3 2026, its #77 holding.
Linden Thomas Advisory Services first reported a position in Kiniksa Pharmaceuticals in Q2 2023 and has held it in 14 quarters since.
Linden Thomas Advisory Services's Kiniksa Pharmaceuticals position peaked at $5.86M in Q1 2026.
58 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.